Baker Bros. Advisors LP Immatics N.V. Transaction History
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
A detailed history of Baker Bros. Advisors LP transactions in Immatics N.V. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 6,443,398 shares of IMTX stock, worth $45.6 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
6,443,398
Previous 6,443,398
-0.0%
Holding current value
$45.6 Million
Previous $74.9 Million
1.81%
% of portfolio
0.79%
Previous 1.0%
Shares
9 transactions
Others Institutions Holding IMTX
# of Institutions
101Shares Held
75.8MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$70.7 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$68.4 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$57.2 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$52.2 Million0.05% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.9MShares$27.6 Million1.61% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $539M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...